1. Home
  2. PSNYW vs BNR Comparison

PSNYW vs BNR Comparison

Compare PSNYW & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

PSNYW

Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

HOLD

Current Price

$7.09

Market Cap

268.4M

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$20.65

Market Cap

233.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNYW
BNR
Founded
2017
2014
Country
Sweden
China
Employees
2547
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.4M
233.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PSNYW
BNR
Price
$7.09
$20.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.4K
64.2K
Earning Date
03-06-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,034,261,000.00
$75,749,382.00
Revenue This Year
N/A
$136.32
Revenue Next Year
$79.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.56
52 Week Low
$0.09
$2.18
52 Week High
$0.61
$24.18

Technical Indicators

Market Signals
Indicator
PSNYW
BNR
Relative Strength Index (RSI) 79.76 56.81
Support Level $6.23 $19.49
Resistance Level $7.50 $21.57
Average True Range (ATR) 0.76 1.80
MACD 0.25 -0.07
Stochastic Oscillator 86.22 58.32

Price Performance

Historical Comparison
PSNYW
BNR

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: